Profil GmbH   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Neuss Germany (1999)

Organization Overview

First Clinical Trial
2001
NCT00982254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Profil GmbH | Profil GmbH Mainz | Profil GmbH, Neuss, Germany | Profil Institute | Profil Institute for Clinical Research, Inc. | Profil Institute for Clinical Research Inc.855 3rd Avenue, Suite 4400Chula VistaCA 91911, USA | Profil Institute for Clinical Research, Inc.855 Third Avenue, Suite 4400Chula Vista, CA 91911 | Profil Institute for Clinical Research Incorporated | Profil Institute for Clinical Research, Inc. (PICR) | Profil Institute for Metabolic Research | Profil Institute for Metabolic Research GmbH | Profil Institute of Clinical Research | Profil Institute of Clinical Research, Inc. | Profil Institut Für Stoffwechselfforschung GmbH | Profil Institut for Clinical Research Inc. | Profil Institut fur Stoffwechselforschung GmbH | Profil Institut für Stoffwechselforschung GmbH | Profil Institut für Stoffwechselforschung GmbH Hellersbergstr. 9 D-41460 Neuss | Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 | Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9] | Profil Mainz GmbH | Profil Mainz GmbH & Co KG | Profil Neuss, Germany | Profil Neuss, GmbH | Profil Neuss GmbH Neuss, Germany, 41460

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Albuminuria (Phase 3)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Fatty Liver (Phase 2)

Gastroesophageal Reflux (Phase 1)

Glucose Intolerance (Phase 2)

Hypertension (Phase 3)

Hypoglycemia (Phase 2)

Insulin Resistance (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overweight (Phase 2)

Phenylketonurias (Phase 1)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 107
  • # of Trial APIs: 44